Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Carol Wasilauskas"'
Autor:
Giske Ursin, Beth A. Reboussin, Gail A. Greendale, Stacey Slone, Malcolm C. Pike, Carol Wasilauskas, Shana L. Palla
Publikováno v:
Journal of Clinical Oncology. 22:2842-2848
Purpose Postmenopausal estrogen and progestin therapy (EPT) increases mammographic percent density and breast cancer risk substantially more than does estrogen therapy alone. We determined whether increases in serum estrone as a function of treatment
Autor:
Carol Wasilauskas, Helmut G. Schrott, Roger Sherwin, Peter D. Wood, Santica M. Marcovina, Valery T. Miller, Mark A. Espeland, Trudy L. Bush
Publikováno v:
Circulation. 97:979-986
Background —Postmenopausal hormone therapy has been reported to decrease levels of lipoprotein (Lp)(a) in cross-sectional studies and small or short-term longitudinal studies. We report findings from a large, prospective, placebo-controlled clinica
Autor:
Carol Wasilauskas, Peter D. Wood, Marcia L. Stefanick, Gerald Kessler, Kenneth Lippel, H B Wells
Publikováno v:
Controlled Clinical Trials. 16:36-53
Autor:
Gail A. Greendale, Beth A. Reboussin, Stacey Slone, Giske Ursin, Carol Wasilauskas, Malcolm C. Pike
Publikováno v:
Journal of the National Cancer Institute. 95(1)
Background: Mammographic density is an independent risk factor for breast cancer. Postmenopausal hormone use is associated with an increase in mammographic density, but the magnitude of the density increase is unknown. Methods: Baseline and 12-month
Autor:
Carol Wasilauskas, Margaret K. James, Leah Holloway, Robert Marcus, Joseph Kelaghan, Bradley Wells, Gail A. Greendale
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 14(9)
We assessed the associations of eight bone turnover markers (BTMs) with baseline and 1-year percentage changes in lumbar spine and hip bone mineral density (BMD) of 293 postmenopausal women undergoing treatment with hormone replacement therapy (HRT)
Autor:
Carol Wasilauskas, Claudine Legault
Publikováno v:
Controlled Clinical Trials. 17:S67-S68
Autor:
Carol Wasilauskas
Publikováno v:
Controlled Clinical Trials. 15:101-102
Autor:
L K Olson, Trudy L. Bush, O Gatewood, A Sie, Elizabeth Barrett-Connor, Carol Wasilauskas, Beth A. Reboussin, H R Singh, L W Bassett, Gail A. Greendale
Publikováno v:
Annals of Internal Medicine. 130:262
age of women with density grade increases was 0% (95% CI, 0.0% to 4.6%) in the placebo group, 3.5% (CI, 1.0% to 12.0%) in the CEE group, 23.5% (CI, 11.9% to 35.1%) in the CEE plus cyclic MPA group, 19.4% (CI, 9.9% to 28.9%) in the CEE plus daily MPA
Autor:
Myra Carpenter, Virginia J. Howard, Hope Bryan, Jan L. Smith, Sara Quandt, Carol Wasilauskas, Elizabeth G. Sides
Publikováno v:
Controlled Clinical Trials. 19:S100
Publikováno v:
Controlled Clinical Trials. 19:S52